BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Baxter
Healthtrust
Farmers Insurance
Boehringer Ingelheim
Moodys
Argus Health
QuintilesIMS
McKesson
Dow

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,379,785

« Back to Dashboard

Summary for Patent: 4,379,785
Title: Heterocyclic substituted sulfonyl ureas, and their use
Abstract:What are disclosed are sulfonyl ureas of the formula ##STR1## in which R.sup.1, X and Y are as defined in the specification, and their physiologically acceptable salts, pharmaceutical formulations on the basis of these compounds, and their use in the treatment of diabetes.
Inventor(s): Weyer; Rudi (Kelkheim, DE), Hitzel; Volker (Hofheim am Taunus, DE), Geisen; Karl (Frankfurt am Main, DE), Regitz; Gunter (Bad Soden am Taunus, DE)
Assignee: Hoechst Aktiengesellschaft (Frankfurt am Main, DE)
Application Number:06/217,524
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 4,379,785

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,379,785

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany2951135Dec 19, 1979

International Patents Family Members for US Patent 4,379,785

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 230989 ➤ Subscribe
Argentina 231131 ➤ Subscribe
Argentina 240922 ➤ Subscribe
Austria 6934 ➤ Subscribe
Australia 538129 ➤ Subscribe
Australia 6552380 ➤ Subscribe
Canada 1167033 ➤ Subscribe
Germany 2951135 ➤ Subscribe
Germany 3067390 ➤ Subscribe
Denmark 156434 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
UBS
Novartis
Chinese Patent Office
Cerilliant
AstraZeneca
Fuji
Moodys
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot